<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Non Zero Design - Medium]]></title>
        <description><![CDATA[Creative Direction and Design Thinking for early-stage venture backed businesses. - Medium]]></description>
        <link>https://medium.com/non-zero-design?source=rss----16b2d3138c21---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>Non Zero Design - Medium</title>
            <link>https://medium.com/non-zero-design?source=rss----16b2d3138c21---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 14:57:15 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/non-zero-design" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Prosthetics and Policy: The Urgent Case for Modernizing India’s Medical Device Regulation]]></title>
            <link>https://medium.com/non-zero-design/prosthetics-and-policy-the-urgent-case-for-modernizing-indias-medical-device-regulation-a73c2f1722c8?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/a73c2f1722c8</guid>
            <category><![CDATA[medical-device-rules]]></category>
            <category><![CDATA[device-surveillance]]></category>
            <category><![CDATA[quality-standards]]></category>
            <category><![CDATA[prosthetic-regulation]]></category>
            <category><![CDATA[prosthetics]]></category>
            <dc:creator><![CDATA[Shreyash Parsewar]]></dc:creator>
            <pubDate>Wed, 17 Sep 2025 07:44:42 GMT</pubDate>
            <atom:updated>2025-09-17T07:44:22.930Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*PAlFo_Olk6gF4JVqp2z9Dg.png" /></figure><p><strong>Imagine losing a limb and getting it replaced by a device that cracks in weeks, cuts into your skin, and leaves you nowhere to complain.</strong></p><p>For over <strong>7.5 million Indians</strong>, this isn’t a horror story. It’s reality. According to the World Health Organization, those people require prosthetic or orthotic devices<a href="https://www.who.int/publications/i/item/9789241512480">(source)</a>, with the majority being lower-limb amputees<a href="https://www.wjgnet.com/2307-8960/full/v11/i30/7261.htm">(source)</a>. Most critically, amputations predominantly affect <strong>working-age adults (20–40 years)</strong>, indicating a devastating impact on India’s workforce<a href="https://www.wjgnet.com/2307-8960/full/v11/i30/7261.htm">(source)</a>.</p><p>In India, prosthetics are more than just tools they are mobility, dignity, and survival. Yet, they remain one of the least protected medical devices under our laws.</p><h3>A Long History of Silence</h3><p>For the longest time, most prosthetic limbs in India were sold as <strong>“non-notified devices”</strong>. That means they weren’t officially recognized as medical devices under the law and so, they weren’t regulated. No mandatory quality checks. No certification. No required documentation of safety, durability, or biocompatibility. If a device failed, there was <strong>no reporting mechanism</strong>, no recall system, and no accountability. The risk and the cost was entirely the user’s.</p><h3>A Gap That Hurts Millions</h3><p>Prosthetics aren’t “luxury” devices. They’re essential for everything from walking your child to school to keeping your job. Yet, WHO estimates that <strong>0.5% of India’s population</strong> needs prosthetic or orthotic devices <a href="https://www.who.int/publications/i/item/9789241565479">(source)</a>, while a 2021 meta-analysis shows <strong>less than 10%</strong> of those with limb loss have access to functional prosthetics <a href="https://doi.org/10.4103/jme.jme_135_20">(source)</a>. Access is worst in <strong>rural and underserved regions</strong>, where low-quality devices often become the only option.</p><h3>The Law Finally Catches Up But Only on Paper</h3><p>After decades of silence and inaction, a crucial shift finally arrived in 2020, when the Indian government expanded the <em>Medical Devices Rules, 2017</em> to classify all medical devices including prosthetics under the <em>Drugs and Cosmetics Act, 1940</em> <a href="https://cdsco.gov.in/">(source)</a>.</p><p>This was a landmark move. It introduced a risk-based classification system:<br><strong>Class A</strong>: Low risk (e.g., simple aids)<br><strong>Class B/C</strong>: Moderate to high risk (e.g., limb prosthetics, orthotics)<br><strong>Class D</strong>: High risk (e.g., implantable cardiac devices)</p><p>This should have meant stricter testing, traceable manufacturing, and accountable distribution for Class B/C prosthetics.<br><strong>The problem?</strong> Enforcement is weak. Awareness among users and even smaller clinics is minimal. For most, nothing has changed.</p><h3>What the Rest of the World Gets Right</h3><p>While India continues to play catch-up, other nations have long treated prosthetic limbs as essential healthcare not optional accessories.<br>These countries don’t just certify devices. They create feedback loops between users, doctors, and regulators. They act when things go wrong. They build systems rooted in transparency and accountability.</p><p>Here’s what that looks like:</p><ul><li><a href="https://www.fda.gov/medical-devices"><strong>FDA (USA)</strong></a><strong>(Food and Drug Administration)</strong>: Medical devices are categorized by risk. Prosthetics typically fall under Class II, requiring a <strong>510(k) clearance</strong> to show they are “substantially equivalent” to existing safe devices. High-risk or innovative solutions undergo <strong>Premarket Approval </strong><a href="https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-approval-pma"><strong>(PMA)</strong></a> with clinical trials and long-term data (<a href="https://www.fda.gov/">FDA.gov</a>).</li><li><a href="https://single-market-economy.ec.europa.eu/single-market/goods/ce-marking_en"><strong>CE Mark (EU)</strong></a><strong>(European Conformity)</strong>: Under the EU Medical Device Regulation <a href="https://eur-lex.europa.eu/eli/reg/2017/745/oj/eng">(MDR 2017/745)</a>, manufacturers must submit a detailed technical file, clinical data, and undergo audits by independent <strong>Notified Bodies</strong>. Continuous <strong>post-market surveillance</strong> is mandatory<a href="https://single-market-economy.ec.europa.eu/">(source)</a>.</li><li><strong>ISO Standards</strong>:</li><li><a href="https://www.iso.org/standard/59752.html"><strong>ISO 13485</strong></a>: Ensures manufacturers have a quality management system specific to medical devices.</li><li><a href="https://www.iso.org/standard/70205.html"><strong>ISO 10328</strong></a>: Defines rigorous structural testing for lower-limb prosthetics to simulate real-life use, impact, and wear.</li><li><a href="https://www.iso.org/standard/68936.html"><strong>ISO 10993</strong></a>: Sets standards for biocompatibility critical for skin safety and long-term wear.</li><li><a href="https://www.iso.org/standard/79495.html"><strong>ISO 8549–1</strong></a>: Establishes standardized terminology for upper- and lower-limb prosthetics and orthotics.</li><li><a href="https://www.iso.org/standard/69569.html"><strong>ISO 13857</strong></a>: Specifies safety distances to prevent hand or arm access to hazardous machinery, ensuring safe prosthetic interaction.</li><li><a href="https://www.iso.org/standard/90287.html"><strong>ISO 13404–2</strong></a>: Covers classification and description of upper-limb orthoses for supporting or correcting deformities.</li></ul><p>Together, these frameworks prioritize one thing above all: the <strong>user experience</strong>. They assume failure is unacceptable and that every user deserves protection backed by science, not guesswork.</p><h3>What Needs to Change in India</h3><ol><li><strong>Enforce the Rules</strong></li></ol><ul><li>Manufacturers must register, test, and certify every prosthetic device.</li><li><a href="https://cdsco.gov.in/opencms/opencms/en/Home/">CDSCO</a>(<strong>Central Drugs Standard Control Organization</strong>) needs more trained inspectors, labs, and technical staff to enforce the MDR(Medical Devices Rules).</li></ul><p><strong>2. Mandate Post-Market Surveillance</strong></p><ul><li>India needs a <strong>centralized reporting platform</strong> for device failures, like <a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm">FDA’s MAUDE system</a>.</li><li>Every clinic, user or distributor should be able to log complaints.</li></ul><p><strong>3. Subsidize Quality for the Poor</strong></p><ul><li>Functional prosthetics can cost upwards of Rs. 50,000. The government must support schemes like <a href="https://depwd.gov.in/en/adip/#:~:text=The%20ADIP%20Scheme%20is%20in,by%20reducing%20the%20effects%20of">ADIP(Assistance to Disabled Persons for Purchase/Fitting of Aids/Appliances)</a> with quality-linked subsidies.</li></ul><p><strong>4. Public-Private Partnerships</strong></p><ul><li>India can learn from models like <a href="https://www.nice.org.uk/"><strong>UK’s NICE</strong></a>, which uses cross-disciplinary panels to review evidence and set device guidelines.</li></ul><p><strong>5. Build a Quality Culture</strong></p><ul><li>Regulation isn’t just a formality, it’s how we ensure that prosthetics meet basic standards of safety and reliability. It ensures users aren’t left alone when things go wrong and builds confidence when things work as promised.</li></ul><h3>The Bottom Line</h3><p>A prosthetic isn’t a gadget. It’s part of your body.<br>They should be safe, durable, and designed to serve. Not fail silently or injure the people relying on them.<br>India already has the talent, technology, and laws to build a better system. What’s missing is consistent enforcement and a culture of accountability.<br>Because when we regulate prosthetics, we don’t just improve devices.</p><p><strong>It’s about restoring trust, mobility, and dignity one person at a time.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a73c2f1722c8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/prosthetics-and-policy-the-urgent-case-for-modernizing-indias-medical-device-regulation-a73c2f1722c8">Prosthetics and Policy: The Urgent Case for Modernizing India’s Medical Device Regulation</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Addressing Child Safety in Indian Medication Packaging Regulations]]></title>
            <link>https://medium.com/non-zero-design/addressing-child-safety-in-indian-medication-packaging-regulations-e26d4ee3e654?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/e26d4ee3e654</guid>
            <category><![CDATA[packaging]]></category>
            <category><![CDATA[india]]></category>
            <category><![CDATA[children]]></category>
            <category><![CDATA[design]]></category>
            <category><![CDATA[medicine]]></category>
            <dc:creator><![CDATA[Sanjana]]></dc:creator>
            <pubDate>Tue, 16 Sep 2025 13:13:12 GMT</pubDate>
            <atom:updated>2025-09-16T13:12:45.821Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*kx3WhK-z_8wjIjMBWFSmyQ.jpeg" /></figure><p>While working on medication management for the elderly, we stumbled upon an equally urgent concern, this time at the other end of the age spectrum. We found ourselves asking: <em>Are our medicines packaged safely enough for children?</em></p><p>The answer was sobering. In most Indian households, they’re not.</p><p>Despite being life-saving for adults, many commonly used medications can cause serious harm , even death, if accidentally ingested by a child. Yet, nearly all medicines in India are packaged in formats that are easy to open, not just for adults but for children too.</p><p>This is more than a packaging oversight. It’s a widespread yet preventable risk and one that’s barely being talked about.</p><h3>The Reality: Accidental Poisoning Is Far More Common Than We Think</h3><p>The data paints a clear and deeply concerning picture. In a <a href="https://www.indianpediatrics.net/mar2017/mar-246-247.htm">hospital-based study from Delhi</a>, <strong>75% of poisoning cases involved children under five</strong>, and <strong>17% of these were caused by</strong> accidental ingestion of medicines, making it the single most common cause of childhood poisoning in that setting.</p><p>Zooming out to a national level, <a href="https://pubmed.ncbi.nlm.nih.gov/10771987/?utm_source=chatgpt.com">research published in the Indian Journal of Pediatrics</a> estimates that over <strong>90% of childhood poisoning cases in India result from accidental ingestion of medicines</strong>. These numbers are not isolated. They’re echoed by doctors in emergency departments who regularly see children brought in after consuming adult medications, painkillers, iron tablets, antihistamines, even heart medications left within reach at home.</p><p>These incidents cut across socio-economic backgrounds, urban and rural alike.</p><h3>Why Does Unsafe Packaging Remain the Norm?</h3><p>For something so high-risk and avoidable, it’s natural to ask, <em>Why hasn’t this changed?</em></p><p>There are a few overlapping reasons:</p><ul><li><strong>No regulatory mandate:</strong> India’s <a href="https://cdsco.gov.in/opencms/opencms/en/Acts-Rules/">Drugs &amp; Cosmetics Act</a> does not require medications to be sold in child-resistant packaging. As a result, manufacturers are not obligated to change their practices.</li><li><strong>Low public awareness:</strong> Most caregivers don’t know what child-resistant packaging (CRP) is or that it even exists and therefore can’t demand it.</li></ul><blockquote>Child-resistant packaging (CRP), also known as special packaging, is <strong>designed to be difficult for young children to open, while still being relatively easy for adults to use</strong>. This type of packaging is crucial for products that could be harmful if ingested, such as medications, household chemicals, and certain pesticides. The goal is to reduce the risk of accidental poisoning in children under five years of age.</blockquote><ul><li><strong>Export vs. domestic standards:</strong> Ironically, Indian pharmaceutical companies do manufacture CRP-compliant packaging but mostly for <strong>export markets</strong>. For medicines sold in India, such safety features are largely absent.</li><li><strong>Lack of perceived urgency:</strong> In the absence of industry pressure or consumer demand, there’s limited momentum to act.</li></ul><p>In short, it’s a mix of regulatory gaps, market inertia, and public unawareness; a dangerous combination when it comes to child safety.</p><h3>What Happens When Child Resistant Packaging (CRP) Is Taken Seriously?</h3><p>Fortunately, there are global examples that show what’s possible when child safety becomes a priority.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/980/1*YiNhYZpyCljYYQgnsmM_XA.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/899/1*Un5l__4kZHrv5aRC7y1IwA.png" /></figure><p>When the <strong>United States passed the </strong><a href="https://www.cpsc.gov/Business--Manufacturing/Business-Education/Business-Guidance/PPPA"><strong>Poison Prevention Packaging Act in 1970</strong></a>, which made child-resistant packaging mandatory for household drugs, poisoning-related deaths among children dropped by nearly <strong>45%</strong> over the next decade.</p><p>Similar mandates now exist in the <strong>UK, Australia, the EU</strong>, and several other countries. These policies are backed by strict enforcement and public awareness campaigns, making CRP the default, not the exception.</p><p>The impact isn’t just limited to fewer hospital visits. CRP also builds <strong>long-term public trust in medication safety</strong>, reduces caregiver anxiety, and strengthens pharmaceutical reputation.</p><p>India isn’t behind on technology or materials, just policy.</p><h3>What’s Already Possible in India</h3><p>The good news is: India already has the capabilities to roll out CRP solutions at scale.</p><p>Companies like <strong>Bilcare Research</strong> are already manufacturing <strong>child-resistant blister foils and cap systems</strong> for clients overseas. Products like <a href="https://www.cphi-online.com/product/cr-foil-crispak/"><strong>Crispak PP</strong></a> meet international CRP standards and are being used for export to highly regulated markets.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*bap7WnquJ8O_opq_csKKNA.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/758/1*0xvevqb62_ISlxoPgb0h3w.png" /></figure><p>Indian packaging innovators are not lacking in technology or design, they’re already part of the global supply chain for safety-first solutions.</p><p>But within India, these same innovations are barely being used.</p><p>What’s missing is a clear policy direction and incentive structures that reward early adopters. In parallel, public health campaigns can help shift consumer awareness, making caregivers more likely to ask: <em>Is this safe for my child?</em></p><h3>So, What Needs to Change?</h3><p>To make CRP mainstream in India, we don’t need to start from scratch just shift priorities:</p><ul><li><strong>Introduce regulatory mandates</strong>: Begin with high-risk medications those commonly used in households and particularly harmful in small doses (like iron, cardiac, or antidepressant drugs).</li><li><strong>Encourage voluntary adoption</strong>: Until policy catches up, Pharma companies can lead by example, showing that safety-first packaging can coexist with profitability.</li><li><strong>Support local manufacturers</strong>: Recognise and promote Indian packaging firms already producing CRP for exports.</li><li><strong>Drive public awareness</strong>: Caregivers, paediatricians, and pharmacists all need to be part of the conversation. If people don’t know this is a risk or that a safer alternative exists, they won’t demand better.</li></ul><p>Change doesn’t always come from regulation alone. It can start from small shifts, a Pharma company launching a pilot CRP line, a design firm experimenting with safer formats, or a public health nonprofit raising awareness in schools and clinics.</p><p><strong>Have you come across efforts in India, small or large, that are already pushing the needle on child-safe packaging?</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e26d4ee3e654" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/addressing-child-safety-in-indian-medication-packaging-regulations-e26d4ee3e654">Addressing Child Safety in Indian Medication Packaging Regulations</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Can Good Design Exist In A Heavily Regulated World?]]></title>
            <link>https://medium.com/non-zero-design/can-good-design-exist-in-a-heavily-regulated-world-e54e83c02af5?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/e54e83c02af5</guid>
            <category><![CDATA[fda-medical-device]]></category>
            <category><![CDATA[medical-device-design]]></category>
            <category><![CDATA[medtech-solutions]]></category>
            <category><![CDATA[medical-innovation]]></category>
            <category><![CDATA[regulatory-compliance]]></category>
            <dc:creator><![CDATA[Kamayani]]></dc:creator>
            <pubDate>Tue, 16 Sep 2025 13:12:13 GMT</pubDate>
            <atom:updated>2025-09-16T13:12:10.206Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*msH6FSkboTvY-kWMl0vbng.jpeg" /></figure><p>Medical technology has reshaped the way we deliver and experience healthcare. Yet for every elegant diagnostic tool or sleek wearable that enters the market, there are hundreds of ideas slowed, or stopped, by regulation. MedTech operates in one of the most controlled environments across industries, and rightly so. When lives are at stake, safety, accountability, and efficacy are non-negotiable.</p><p>But this leads us to a difficult question: <em>Can good design truly thrive in such a highly regulated space?</em></p><p>As designers, engineers, and innovators, we often walk a tightrope between compliance and creativity. The challenge lies not only in building life-saving products, but in doing so within a maze of global regulatory frameworks, all while creating experiences that are intuitive, inclusive, and effective.</p><h3>The Architecture of Constraint</h3><p>Think of regulation as the structural skeleton of a building. It shapes everything around it.</p><p>In MedTech, regulatory frameworks like <a href="https://www.iso.org/standard/59752.html">ISO 13485</a> (medical device quality management), <a href="https://www.iso.org/standard/63179.html">IEC 62366</a> (usability engineering and safety), and regional standards create similar constraints and play a similar role. But unlike architecture, these systems were rarely created with the <strong>end user’s experience</strong> in mind.</p><p>Let’s take a closer look:</p><ul><li>The U.S. FDA’s <a href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820/subpart-C/section-820.30"><strong>CFR 820.30</strong></a> outlines strict design controls, requiring documentation of user needs, thorough verification and validation, and formal risk management.</li><li>Europe’s <a href="https://eur-lex.europa.eu/eli/reg/2017/745/oj/eng"><strong>MDR 2017/745</strong></a> added even more complexity, introducing hundreds of clauses, around clinical evaluation, post-market surveillance, and traceability, that significantly raised the bar for compliance.</li></ul><p>In contrast, India’s <a href="https://cdsco.gov.in/opencms/opencms/en/Acts-and-rules/Medical-Devices-Rules/"><strong>MDR 2017</strong></a> is still maturing. While it aligns with global frameworks on paper, enforcement remains inconsistent, particularly when it comes to usability and human factors.</p><p>Yet here lies the fundamental tension: <strong>Most regulatory systems are product-first, not user-first.</strong></p><p>And this is true across the board: from the FDA’s device classifications to Europe’s documentation-heavy MDR and in emerging markets like India that are still trying to balance safety with user experience.</p><h3>When Standards Miss the Human Element</h3><p>Take <strong>ISO 13485</strong>, for example. It ensures documentation, traceability, and risk control, vital aspects for safety. But it says almost nothing about how users actually interact with the device.</p><p>As a result, design often becomes an afterthought. Unlike in consumer tech, where designers help shape the product from day one, MedTech design teams often enter too late. By then, most specs are locked. The job becomes one of “making things look better,” not rethinking how they work.</p><p><strong>IEC 62366–1</strong> tries to address this gap by introducing usability engineering. But it frames usability primarily through the lens of safety, minimizing risk, avoiding mistakes, rather than experience.</p><p>That’s important. But it’s also limiting.</p><p>Good usability isn’t just about preventing errors. It’s also about <strong>supporting clinical decisions, reducing cognitive burden, and improving clarity</strong> in fast-moving clinical settings.</p><p>Unfortunately, the system today encourages design for paperwork, not for people.</p><h3>The Design Deficit: Real-World Consequences</h3><p>This disconnect between design thinking and regulatory systems isn’t theoretical. It affects care delivery every day. Poor design choices translate into real-world inefficiencies, frustration, and, at times, compromised care.</p><p>Take the <strong>traditional glucose meter.</strong> Many are poorly designed, with tiny screens, cryptic error codes, and multi-step calibration. Nurses lose time interpreting them. Patients find home testing daunting. Errors become more likely.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*T3Ar5eBAfnsS7lVWEmXBjg.jpeg" /></figure><p>Now compare that to the <strong>FreeStyle Libre,</strong> a continuous glucose monitor that shows the same data through intuitive graphs, color-coded trends, and smartphone integration.</p><p>The core function is the same. But the user experience is vastly better: faster decision-making, lower cognitive burden, and greater user confidence.</p><p>This difference isn’t just aesthetic. It’s systemic.</p><p>Well-designed MedTech leads to fewer errors, faster decisions, higher adoption, and better patient outcomes. Yet even today, most regulatory systems do not formally recognize design quality as a safety factor.</p><h3>Finding Cracks Where Innovation Grows</h3><p>Despite these constraints, there are spaces where design is beginning to thrive <strong>within</strong> regulation.</p><p>A good example is the <strong>Apple Watch ECG feature</strong>, which received FDA clearance. Apple didn’t sidestep regulation. They worked through it.</p><p>Usability validation was built into both their regulatory strategy and product design through simplified interfaces, clear feedback loops, and seamless integration with existing clinical systems.</p><p>As a result, the feature not only met regulatory standards but also potentially saved lives. There are documented cases of the watch detecting atrial fibrillation and prompting users to seek care in time <a href="https://timesofindia.indiatimes.com/technology/social/how-the-apple-watch-series-10-saved-an-elderly-womans-life-by-detecting-irregular-heartbeat/articleshow/114069227.cms">[source]</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*JeiyZnTYKtVp0V0Vv0OVNQ.jpeg" /></figure><p>In this case, regulation and design weren’t in conflict. They worked together.</p><p>The same is true for other successful wearables. They don’t succeed despite regulatory constraints, but because they treat those constraints as design problems to solve.</p><p>Even in developing regulatory systems, like in India, progress is happening. Initiatives such as the <strong>National Digital Health Mission</strong> (NDHM) and alignment with <strong>IMDRF</strong> (International Medical Device Regulators Forum) standards are nudging the system toward a future where <strong>good design isn’t optional; it’s expected</strong>.</p><p><strong>The key lies in understanding that regulation and user experience aren’t opposing forces; they’re different languages describing the same goal: effective, safe healthcare delivery.</strong></p><h3>Reframing the Design Challenge</h3><p>So. Maybe we’re asking the wrong question.</p><p>Instead of “Can good design exist in regulated MedTech?”, we should ask</p><p><strong><em>“How can design adapt and still thrive under regulations?”</em></strong></p><p>That shift changes everything. It asks us to:</p><ul><li>See design as <strong>strategic</strong>, not decorative</li><li>Use regulation as a <strong>framework</strong>, not a blockade</li><li>Involve compliance and regulatory experts <strong>from day one</strong></li><li>Treat documentation and traceability as <strong>part of the design process</strong>, not as afterthoughts</li></ul><h3>Designing Within and Through Regulation</h3><p>Yes, MedTech will always be slow-moving and document-heavy. But those same demands: clarity, proof and validation, are things good design can excel at.</p><p>The opportunity lies in how we work:</p><ul><li>Bring design, engineering, and compliance into the same room early</li><li>Use iterative prototyping and testing to validate both usability and compliance</li><li>Translate regulatory requirements into actual interaction models and user flows</li><li>Leverage digital tools to document everything cleanly, traceably, and in real time</li></ul><p>In this way, <strong>design becomes the bridge</strong> between regulatory complexity and human understanding. It converts rules into real-world experiences.</p><h3>The Future of Regulated Design</h3><p>As telemedicine, AI, and point-of-care diagnostics reshape healthcare, regulation and design must evolve together.</p><p>The future isn’t compliance vs. creativity. It’s <strong>compliance through creativity</strong>.</p><p>Design teams will need new skills like regulatory literacy, systems thinking, and cross-functional fluency. And we’ll need new ways of measuring success, ones that combine patient experience with safety, effectiveness, and auditability.</p><h3>Redefining “Good Design” in MedTech</h3><p>In this context, good design is not just about speed or visual polish. It’s about:</p><ul><li>Reducing cognitive load in high-pressure environments</li><li>Designing accessible tools for diverse users</li><li>Supporting decisions with clear information</li><li>Simplifying complexity <strong>without</strong> compromising safety</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*HWEOJhNel9Ing84J47KLqQ.jpeg" /><figcaption>eg: Infusion pumps adapt to context: layered and integrated in the US, simplified and accessible in India.</figcaption></figure><p>And it’s also about <strong>trust</strong>. Creating predictable, consistent experiences that users, patients, and clinicians alike can rely on, even in the most regulated spaces.</p><p>So, can good design exist in heavily regulated environments?</p><p>Absolutely.</p><p>But only if we evolve what we mean by “good design.”</p><p><strong>It’s not about breaking the rules. It’s about knowing them well enough to design around, within, and through them.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e54e83c02af5" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/can-good-design-exist-in-a-heavily-regulated-world-e54e83c02af5">Can Good Design Exist In A Heavily Regulated World?</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Designing MedTech in India: How Startups Can Win Amid Regulatory Chaos]]></title>
            <link>https://medium.com/non-zero-design/designing-medtech-in-india-how-startups-can-win-amid-regulatory-chaos-b90223a70077?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/b90223a70077</guid>
            <category><![CDATA[medical-device-regulation]]></category>
            <category><![CDATA[healthtech-startup]]></category>
            <category><![CDATA[healthcare-innovations]]></category>
            <category><![CDATA[indian-healthtech]]></category>
            <category><![CDATA[indian-healthcare]]></category>
            <dc:creator><![CDATA[Kamayani]]></dc:creator>
            <pubDate>Fri, 18 Jul 2025 09:10:53 GMT</pubDate>
            <atom:updated>2025-07-18T09:10:53.584Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*cgvpq4sjKpcXNdQGZ4jJtw.jpeg" /><figcaption>Designing MedTech In India: How Startups Can Win Amid Regulatory Chaos</figcaption></figure><p>India’s medical technology sector presents a compelling investment thesis: a $12 billion market in 2023–24 projected to reach $50 billion by 2030. Yet for startups, success demands more than riding the growth wave, it requires navigating regulatory complexity, building robust design processes, and leveraging government incentives strategically.</p><h3>Market Reality: Opportunity Amid Import Dependence</h3><p>India’s MedTech landscape reveals both promise and challenge. While over 70% of Indian MedTech startups integrate AI, IoT, and cloud computing for diagnostics and remote monitoring, the country remains 80–85% import-dependent. <strong>This creates a strategic opening for domestic startups willing to build comprehensive solutions.</strong></p><p>The gap isn’t just manufacturing capacity. As Anish Bafna, MD &amp; CEO of Healthium Medtech, explains: “We’d like to make more products, but would need around 200 component suppliers. The component suppliers do not exist in India because the ecosystem is not developed.” This ecosystem void represents both barrier and opportunity for startups that can build integrated supply chains.</p><p>Yet despite these infrastructure challenges, Indian MedTech companies possess unique advantages that position them for success. As Prabhat Maheshwari of Amocare notes, “Our literature, flexibility, and growing expertise give us a competitive edge.” This represents the opportunity amid the chaos; <strong>Indian startups that can navigate regulatory complexity, while building global-standard products, position themselves to capture both domestic growth and international markets.</strong></p><h3>Regulatory Framework: From Friction to Strategic Advantage</h3><p>India’s transition from treating medical devices as “drugs” under the 1940 Drugs and Cosmetics Act to the dedicated Medical Device Rules (MDR) 2017 has created a more structured regulatory environment. The Central Drugs Standard Control Organisation (CDSCO) now operates a risk-based classification system — Class A (low-risk) to Class D (high-risk) — aligned with global standards.</p><p><strong>Strategic Compliance Approach:</strong></p><p><strong>The key is treating regulatory compliance as product strategy, not administrative overhead.</strong> Startups should adopt ISO 13485 <a href="https://www.iso.org/standard/59752.html">[source]</a> quality management systems from early development stages and engage CDSCO before prototyping. This front-loaded approach accelerates approval timelines and builds quality into core processes.</p><p>Dozee, the Bangalore-based remote patient monitoring startup, exemplifies this strategy. By initiating clinical validation studies during development and partnering closely with hospitals for iterative testing, they accelerated their CDSCO approval process. Their contactless monitoring solution, using AI and ballistocardiography, now operates in over 370 hospitals across India while maintaining ISO compliance for international expansion.</p><h3>Design-Driven Development: Implementing User-Centric Methodologies</h3><p>While many MedTech startups recognize the importance of user-centered design, translating this principle into practice requires structured methodologies. The most successful companies implement comprehensive co-design frameworks that systematically engage all stakeholders throughout the development lifecycle.</p><p><strong>Co-Design Framework for MedTech Startups:</strong></p><ol><li><strong>Clinical Partnership Integration</strong>: Establish formal partnerships with healthcare institutions early in the development process. These partnerships should facilitate regular usability studies in real clinical environments.</li><li><strong>Iterative Prototyping with End Users</strong>: Deploy rapid prototyping cycles that include actual healthcare workers and patients. Focus on workflow integration rather than standalone functionality.</li><li><strong>Edge Case Validation</strong>: Test solutions in low-resource settings with poor connectivity and non-specialist users, conditions common across India’s healthcare landscape.</li></ol><p>For Software as Medical Device (SaMD) companies, this approach is particularly critical. Beyond accuracy, solutions must be explainable, auditable, and interoperable within existing healthcare workflows. The upcoming EU Directive 2019/882 <a href="https://eur-lex.europa.eu/eli/dir/2019/882/oj/eng">[source]</a> adds complexity for startups with global ambitions, making early design validation essential.</p><h3>Government Incentives: Leveraging Policy Support Strategically</h3><p>The Production Linked Incentive (PLI) scheme offers significant opportunities for qualifying startups. The scheme provides financial incentives for domestic manufacturing while the Medical Device Parks initiative promises infrastructure support. However, execution varies significantly between states.</p><p>The broader policy ecosystem includes:</p><ul><li><strong>PLI Scheme</strong>: Targets specific MedTech categories with manufacturing incentives</li><li><strong>PRIP Scheme</strong>: Rs 5,000 crore allocated for medical device development and manufacturing</li><li><strong>MedTech Mitra Initiative</strong>: Designed to ease regulatory navigation and capability building</li><li><strong>National Single Window System (NSWS)</strong>: Streamlining approval processes (still evolving)</li></ul><p>The National Medical Devices Policy 2023 signals government commitment, but startups must navigate implementation gaps. State-level execution varies, requiring careful selection of manufacturing locations and partnership strategies.</p><h3>Building Competitive Advantage: Talent and Supply Chain Strategy</h3><p>Beyond leveraging government support, startups must address fundamental ecosystem challenges to build sustainable competitive advantages. The two most critical areas are talent development and supply chain strategy.</p><p>MedTech currently lacks established academic programs and regulatory training infrastructure. This creates both challenge and opportunity for startups willing to invest in capability building.</p><p>Kriya Medical Technologies exemplifies this approach by building in-house learning systems, a costly but strategically necessary investment. As founder Anu Moturi observes, “While India’s regulatory environment for pharma is well-established, MedTech regulations are still developing. There is a need for more clarity and industry involvement.” Companies that invest early in regulatory expertise and clinical partnerships gain significant competitive advantages over those that treat these as afterthoughts.</p><p>This trend toward specialized capability building is gaining momentum across the ecosystem. Organizations, like ours (<a href="https://www.linkedin.com/company/non-zero/posts/?feedView=all">Non-Zero</a>), are establishing dedicated MedTech wings focused on emerging trends and training specialized talent, recognizing that the future of Indian MedTech depends on developing domain-specific expertise.</p><p>The component supplier shortage creates a chicken-and-egg problem: without local demand, suppliers won’t emerge; without suppliers, manufacturers can’t achieve scale economics. Startups should consider strategic partnerships with existing component manufacturers, vertical integration for critical components, or participation in regional supply chain development through government programs.</p><h3>Strategic Recommendations for MedTech Startups</h3><p>Based on the analysis above, successful MedTech startups should follow a phased approach that systematically addresses regulatory, design, and market challenges:</p><p><strong>Phase 1: Foundation Building</strong></p><ul><li>Engage CDSCO and implement ISO 13485 before prototyping</li><li>Establish clinical partnerships for co-design and validation</li><li>Develop regulatory expertise in-house or through strategic partnerships</li></ul><p><strong>Phase 2: Product Development</strong></p><ul><li>Conduct iterative usability studies in real clinical environments</li><li>Focus on workflow integration and edge case performance</li><li>Build for global regulatory standards while addressing local market needs</li></ul><p><strong>Phase 3: Market Entry</strong></p><ul><li>Leverage government incentive programs strategically</li><li>Build supply chain partnerships or vertical integration capabilities</li><li>Plan international expansion from domestic market success</li></ul><h3>Conclusion: Long-Term Competitive Positioning</h3><p>India’s MedTech sector is transitioning from import dependence to innovation leadership. Startups that invest early in regulatory compliance, co-design methodologies, and ecosystem engagement are building products that succeed both domestically and internationally.</p><p>The regulatory complexity and infrastructure gaps that challenge many startups also create moats for those who navigate them successfully. This isn’t just a market opportunity, it’s a moment where strategic thinking and execution can build lasting competitive advantages in a rapidly growing sector.</p><p>For Indian MedTech entrepreneurs, success depends on building the right capabilities to capture this growing market sustainably.</p><p>If you’re a practitioner, innovator, product owner, or someone who sees a gap in the system, we’d love to hear from you.<br>Reach out to us on <a href="https://www.linkedin.com/company/non-zero/posts/?feedView=all">LinkedIn</a> or Check out some of our work &amp; case studies on <a href="https://www.factors.design/">Factors.Design</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b90223a70077" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/designing-medtech-in-india-how-startups-can-win-amid-regulatory-chaos-b90223a70077">Designing MedTech in India: How Startups Can Win Amid Regulatory Chaos</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Designing for Dignity: The Urgent Need for Better Palliative Care in India]]></title>
            <link>https://medium.com/non-zero-design/designing-for-dignity-the-urgent-need-for-better-palliative-care-in-india-856552fac2e0?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/856552fac2e0</guid>
            <category><![CDATA[cancer]]></category>
            <category><![CDATA[design]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[palliative-care]]></category>
            <dc:creator><![CDATA[Sanjana]]></dc:creator>
            <pubDate>Mon, 07 Jul 2025 15:45:42 GMT</pubDate>
            <atom:updated>2025-07-07T15:45:42.403Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*nE6OyLxIk0MzHMnxYnOaOQ.jpeg" /></figure><p>We recently spoke with Dr. Anup Yadav, co-founder of OPSAN, a pioneering palliative care organization in Gurugram, to better understand the urgent need and evolving landscape of palliative care in India. His insights shed light not just on the challenges, but also on the profound opportunities to create a more compassionate, dignified future.</p><h3>Why Palliative Care Matters</h3><p>In India, caring for aging parents and seriously ill relatives is a deeply rooted family responsibility. But with an elderly population expected to exceed a staggering <strong>340 million by 2050</strong>, and chronic illnesses like heart disease, diabetes, and dementia on the rise, many families find themselves overwhelmed.</p><p>Palliative care directly addresses this critical gap. It’s not about giving up; it’s about actively improving quality of life by expertly managing symptoms, providing emotional support, and helping families navigate complex decisions with empathy and clarity. Crucially, palliative care runs alongside curative treatments, helping people with conditions like kidney failure, dementia, neurological disorders, and more not just cancer.</p><h3>The Indian Reality: A Large Gap</h3><p>Globally, research shows early palliative care improves outcomes, enhances well-being, and reduces unnecessary hospital visits. Yet in India, despite an estimated <strong>7–10 million people urgently needing palliative care</strong>, less than 4% actually receive it.</p><p>Why? Services remain heavily concentrated in major cities, leaving rural and semi-urban communities largely underserved. Even with landmark policy moves like India’s National Palliative Care Strategy (2012) and amendments to the NDPS Act (2014) to improve access to pain medications, gaps in implementation persist. Public funding is minimal, and Ayushman Bharat, India’s flagship health insurance scheme offers inconsistent palliative care coverage across states, leaving many families burdened with high out-of-pocket costs.</p><h3>A Grassroots Response to a Systemic Need</h3><p>Despite these systemic hurdles, organizations like OPSAN, co-founded by Dr. Anup, are working to fill the void. OPSAN combines center-based care with home visits, comprehensive caregiver training, and compassionate counseling.</p><blockquote>“Our approach is simple,” says Dr. Anup. “We meet families where they are. Care is more than medication it’s about alleviating suffering in all its forms: physical, emotional, and spiritual.”</blockquote><p>Other pioneering organizations like Pallium India (community-based palliative care), BHT Karunashraya in Bengaluru (renowned hospice models), and CanSupport in Delhi (celebrated home-based care) have each built unique community-driven approaches. Together, they represent a resilient and growing network striving to ensure dignity at life’s most vulnerable moments.</p><h3>Designing a More Dignified Future</h3><p>As India’s population ages and chronic conditions escalate, the need for scalable, empathetic solutions will only grow. And this isn’t just a healthcare challenge it’s a profound design opportunity.</p><p>Here’s how design can reshape the palliative care experience:</p><ul><li><strong>Humanize Information:</strong> Translate medical jargon into clear, compassionate tools that help patients and families understand options without fear.</li><li><strong>Ease Navigation:</strong> Design intuitive digital platforms and clear wayfinding to help families find, access, and coordinate palliative care services seamlessly.</li><li><strong>Improve Care Environments:</strong> Transform home and hospice settings into spaces prioritizing comfort, peace, and emotional well-being.</li><li><strong>Support Caregivers:</strong> Create practical guides, videos, or tactile tools to empower family members with essential caregiving skills.</li><li><strong>Amplify Advocacy:</strong> Use storytelling, data visualization, and user journeys to spotlight systemic gaps and inspire policy change.</li></ul><p>Because the question isn’t whether India needs better palliative care, it’s <strong>how</strong> we harness design, policy, and community engagement to create a comprehensive system that truly supports every individual through one of life’s most challenging transitions.</p><p>Dignity at the end of life shouldn’t be a privilege for the few. It must be a right for all.</p><p>And it’s high time we passionately and intentionally designed for it.</p><p><strong>If you’re a practitioner, innovator, product owner, or someone who sees a gap in the system, we’d love to hear from you. <br>Reach out to us on </strong><a href="https://www.linkedin.com/in/sk-sanjanakalra/"><strong>LinkedIn</strong></a><strong> or Check out some of our work &amp; case studies on </strong><a href="https://www.factors.design/"><strong>Factors.Design</strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=856552fac2e0" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/designing-for-dignity-the-urgent-need-for-better-palliative-care-in-india-856552fac2e0">Designing for Dignity: The Urgent Need for Better Palliative Care in India</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Hands That Heal, Tools That Help: Getting Rural Healthcare Right with Tech]]></title>
            <link>https://medium.com/non-zero-design/hands-that-heal-tools-that-help-getting-rural-healthcare-right-with-tech-215102908706?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/215102908706</guid>
            <category><![CDATA[india]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[design]]></category>
            <category><![CDATA[user-experience]]></category>
            <dc:creator><![CDATA[Shreyash Parsewar]]></dc:creator>
            <pubDate>Thu, 03 Jul 2025 10:50:57 GMT</pubDate>
            <atom:updated>2025-07-03T10:50:57.363Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*n3X85j7VG1YCWpWVJw31qA.png" /></figure><p>The narrative around modern healthcare is dominated by the promise of technology. We envision a future of AI-driven diagnostics, telemedicine consultations bridging vast distances, and health-monitoring apps on every smartphone. For a country like India, with its sprawling rural landscape and doctor-patient ratio challenges, this “MedTech” revolution seems like the perfect prescription.</p><p>But in the dusty lanes of a remote village, far from the polished corridors of urban hospitals, this narrative often breaks down. While technology holds immense potential, its unguided application risks missing the most critical element of healing: <strong>the human touch</strong>. The conversation shouldn’t be about replacing people with pixels, but about pairing technology with the right people. In rural India, the most effective, reliable, and scalable “technology” is a PHC (Primary Health Centre) staff member or an ASHA (Accredited Social Health Activist) or ANM (Auxiliary Nurse Midwife) with the right tools in hand.</p><p>Just 25% of India’s health resources serve nearly 70% of the rural population <a href="https://ballardbrief.byu.edu/issue-briefs/healthcare-access-in-rural-communities-in-india?">(source)</a>. The shortage of doctors, uneven infrastructure, and crushing out-of-pocket expenses (which make up 62% of healthcare spending) leave frontline workers and health centres struggling <a href="https://blog.artivatic.ai/p/the-high-cost-of-healthcare-in-india">(source)</a>. This is the landscape where India’s healthcare ambitions must meet ground realities.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*0ohgcHSOBl8g-pkXH--_uA.png" /><figcaption><a href="https://www.indiatimes.com/trending/social-relevance/asha-workers-india-covid-19-516967.html?picid=1974796">[Image Source]</a></figcaption></figure><h3>Challenges on the Ground</h3><ul><li><strong>Infrastructure Fragility:</strong> Internet may technically reach 95% of villages, but speeds are inconsistent. PHCs (Primary Health Centre) struggle with voltage fluctuations and erratic power <a href="https://www.pib.gov.in/PressReleasePage.aspx?PRID=2040566">(source)</a>. Devices malfunction. Tech tools without maintenance plans often become liabilities.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*8rHytlTs-Jf36XMnSci1MA.png" /><figcaption><a href="https://samvadaworld.com/featured/primary-healthcare-in-india-leveraging-existing-phcs-and-technology-to-ensure-healthcare-for-every-indian/">[Image Source]</a></figcaption></figure><ul><li><strong>Digital Literacy Gap:</strong> ASHAs and ANMs often receive one-time training for any new technology or software but lack continuous support. Even PHC (Primary Health Centre) doctors are sometimes reluctant to rely on software they don’t fully understand or trust.</li><li><strong>Workflow Misfit:</strong> Many digital tools are built without frontline input. Apps require constant data input with poor offline functionality. There’s no accommodation for local dialects or real-life constraints like shared smartphones or low battery. Rather than easing workloads, the tech can become another checklist to tick.</li><li><strong>Trust and Cultural Barriers:</strong> Even when a teleconsultation is available, patients hesitate to trust a screen over a familiar face. Without a community worker mediating the interaction, uptake remains low.</li></ul><h3>Government Intent &amp; Schemes</h3><p><strong>The intent is there.</strong> The Ayushman Bharat Digital Mission (ABDM) envisions universal health records, teleconsultation, and data integration. The Health and Wellness Centre’s under Ayushman Bharat aim to upgrade sub-centers into digitally enabled hubs with lab services, e-pharmacy, and diagnostics <a href="https://www.manoramahealthcare.com/blog/ayushman-bharat-digital-mission-abdm-revolutionizing-indias-healthcare-system/">(source)</a>. The National Health Mission has funded initiatives for mobile health vans, digital training modules for ASHA’s (Accredited Social Health Activist) or ANM’s (Auxiliary Nurse Midwife), and portable diagnostic kits.</p><p><strong>Yet intent hasn’t always translated into implementation.</strong> In many places, tablets given to ASHAs remain unused because they lack local language interfaces or crash frequently. PHCs (Primary Health Centre) often lack stable internet or power backup, making real-time syncing difficult <a href="https://documents1.worldbank.org/curated/en/099081723223028498/pdf/P1750750936a760320bfb9066084a6084bf.pdf">(source)</a>. Schemes that look promising on paper get tangled in procurement delays, lack of on-ground tech support, and poor data interoperability.</p><h3>What’s Working: Pairing the Right Tech With the Right People</h3><p>Some states are already seeing results by embedding digital tools into the existing public health workforce. In Jharkhand and Odisha, Apollo’s Digital Dispensaries have equipped PHCs (Primary Health Centre) and paramedical staff with tele-consultation setups <a href="https://www.weforum.org/stories/2023/08/digital-dispensaries-madhya-pradesh-healthcare/">(source)</a>. Local workers guide patients through virtual appointments, help take vitals, and dispense medicines under remote supervision. These setups have reduced referral rates and allowed remote villages to access specialists without expensive travel.</p><p>In Bihar, ASHA (Accredited Social Health Activist) workers armed with basic tablets tracked maternal health across more than 60 villages. The devices simplified data entry with picture-based forms and voice inputs. Alerts for high-risk pregnancies helped escalate cases in time, and vaccination compliance jumped with automated reminders synced to each ASHA’s (Accredited Social Health Activist) case log <a href="https://www.nec.com/en/press/202002/global_20200209_01.html#:~:text=During%20the%20period%2C%20Accredited%20Social%20Health%20Activists,in%20this%20pilot%20on%20a%20voluntary%20basis.">(source)</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mUhxh6NXoMbxL_duVj78xQ.png" /><figcaption><a href="https://www.smilefoundationindia.org/blog/telemedicine-healthcare-an-important-tool-for-preventive-care/">[Image Source]</a></figcaption></figure><p>In Maharashtra, a pilot program equipped ANMs (Auxiliary Nurse Midwife) with voice-input apps in Marathi, cutting data entry time and helping them focus more on patient interaction during antenatal(Parental) care.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*4fDmEdOBaPN2y5xAwh1LZg.png" /><figcaption><a href="https://theprint.in/ani-press-releases/medtel-is-fulfilling-ndhms-vision-through-tech-enabled-rural-pregnancy-care/">[Image Source]</a></figcaption></figure><p>Even government platforms like eSanjeevani are beginning to adapt some PHCs (Primary Health Centre) in Kerala and Gujarat now use the platform with a local ANM (Auxiliary Nurse Midwife) or health assistant acting as the bridge, translating concerns, sharing vital signs, and following up post-consultation <a href="https://www.pib.gov.in/PressReleasePage.aspx?PRID=1899855">(source)</a>.</p><h3>Conclusion</h3><p>The future of rural healthcare isn’t a choice between humans and hardware. It’s a combination. Technology in the hands of a trained, trusted health worker whether at a PHC or in the field doesn’t just digitize care, it strengthens it.</p><p>We’ve taught machines to think. But can our systems learn to listen to the humans who’ve always been there?</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=215102908706" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/hands-that-heal-tools-that-help-getting-rural-healthcare-right-with-tech-215102908706">Hands That Heal, Tools That Help: Getting Rural Healthcare Right with Tech</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Beyond the Machines: What MedTech Guwahati Really Revealed]]></title>
            <link>https://medium.com/non-zero-design/beyond-the-machines-what-medtech-guwahati-really-revealed-169212457edc?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/169212457edc</guid>
            <category><![CDATA[industrial-design]]></category>
            <category><![CDATA[expo]]></category>
            <category><![CDATA[medical]]></category>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[interface-design]]></category>
            <dc:creator><![CDATA[Kavita Tewari]]></dc:creator>
            <pubDate>Mon, 30 Jun 2025 17:34:32 GMT</pubDate>
            <atom:updated>2025-06-30T17:34:32.231Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*LJpVanz177IX2Q1Rn5-DPw.jpeg" /></figure><p>We went to Guwahati as <strong>Non-Zero</strong>, hoping to explore. We discovered a national medtech crossroads: <strong>The MedTech Expo</strong>. Device makers, policy experts, and healthcare entrepreneurs from across India gathered to showcase their innovations.</p><p>We expected machines. What we got were mindsets.</p><p>Day 1 was still in setup mode, giving exhibitors time to talk. This timing worked well for us. Without crowds, conversations flowed naturally. People shared not just their machines’ functions but their thinking behind creating them.</p><h3>Quickly a pattern emerged:</h3><p><strong>Most Indian medical device companies design their products in-house, led by R&amp;D engineers</strong>. They rarely involve dedicated designers or external design firms.</p><p><em>“Our engineers handle design too,”</em> said a product manager from a surgical equipment manufacturer, pointing to a machine destined for operating rooms.</p><p><em>“Once the tech works, the job is done.”</em> His voice showed complete conviction.</p><p>This approach comes from both necessity and the belief that <strong>design is secondary to functionality</strong>. When asked about usability, many dismissed it as “not critical”.</p><p>Interestingly, several booths displayed machines with <strong>components imported from Germany or China</strong>. They praised these for their “sleeker design” and “international look”.</p><p>Their focus was on chrome finishes and minimalist panels, not on practical benefits like making a nurse’s 12-hour shift easier or reducing a surgeon’s mental workload during procedures.</p><p>To them, design was makeup, not medicine.</p><p>We noticed a Japanese machine with an interface completely in Japanese. When asked about translation plans, the answer was simple:</p><blockquote><em>“No, it will stay like this. We give the users a demo of how to use it. They just need to press two buttons; that’s it.”</em></blockquote><p>The implication was clear: users would memorise which foreign symbols to press after a brief demo. Usability became mere muscle memory: press here, then here, no questions asked.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*KDC7f-kHh0u1y3VdL1aEkw.png" /></figure><p>One of our most valuable conversations was with <strong>Arjun from PBL</strong>, who explained why many Indian medical companies import machines from China.</p><p>“It’s a common belief”, he said, looking around the hall, “that good design only comes from abroad, and you must pay extra for it.”</p><p>He pointed out clear issues with local machines:</p><ul><li>Buttons that were too small to operate comfortably.</li><li>Machine shells that looked like anonymous boxes</li><li>An overwhelming use of colours, making the interface confusing and cluttered.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*otqoV9M0BWp556IeHHj0pQ.png" /><figcaption>Left: A patient monitor imported from China with a bright, organized interface for real-time vitals. Right: A made-in-India ECG machine with a dated, cluttered design showing how usability often takes a backseat to functionality.</figcaption></figure><p>Beyond aesthetics, Arjun highlighted a crucial missing element: <strong>“consideration for the end user”</strong></p><p>Medical environments are high-pressure situations. <strong>“Time is precious. Every action must be precise.”</strong> Hard-to-use machines waste time and increase stress in an already tense environment.</p><p>Throughout the expo, this <strong>fundamental misconception about design kept appearing</strong>.</p><p>Many view design as mere beautification. Functionality takes priority while usability gets ignored. Few understand how good design can reduce mental strain, simplify tasks, and improve accuracy: all vital in healthcare.</p><p>Companies often rely on brand recognition instead. They assume a known name will sell, regardless of how difficult the machine is to use.What we saw wasn’t a lack of talent or ambition. It was a mindset gap.</p><p>Technology keeps advancing. But in the Indian MedTech space, <strong>design hasn’t yet entered the conversation</strong> in a meaningful way. This creates an opportunity: to transform design from decoration into differentiation.</p><p>This visit was our first step into a rapidly growing field that’s still taking shape.</p><p>We’re not experts yet! But we’re listening, learning, and engaging.</p><p>We look forward to more exhibitions, conversations, and challenging questions that help us (and hopefully others) build better.</p><p><strong>See you at the next trade fair.</strong> 👋</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=169212457edc" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/beyond-the-machines-what-medtech-guwahati-really-revealed-169212457edc">Beyond the Machines: What MedTech Guwahati Really Revealed</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Designing for Impact in MedTech: Lessons from the OR and Beyond]]></title>
            <link>https://medium.com/non-zero-design/designing-for-impact-in-medtech-lessons-from-the-or-and-beyond-9c57758b5258?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/9c57758b5258</guid>
            <category><![CDATA[medtech]]></category>
            <category><![CDATA[ai]]></category>
            <category><![CDATA[3d-printing]]></category>
            <category><![CDATA[design]]></category>
            <category><![CDATA[3d-imaging]]></category>
            <dc:creator><![CDATA[Sanjana]]></dc:creator>
            <pubDate>Mon, 30 Jun 2025 17:33:54 GMT</pubDate>
            <atom:updated>2025-07-03T10:21:40.879Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9SmNkiXmMEjqX3K9MeR9pw.jpeg" /></figure><p>When we sat down with Dr. Chandan Juneja, a general and proctologist consultant surgeon from Bangalore with 35+ years of experience, we weren’t sure what to expect. But we knew one thing before diving head-first into the MedTech space as a design agency, we needed to listen first. Because the internet can only tell you so much.</p><p>As a studio that’s worked on 100+ projects across sectors — automotive, fintech, consumer electronics, biotech — we’ve learned that great design doesn’t come from jumping in with ready-made answers. It comes from asking the right questions, adapting to context, and working closely with those who live the problems every day.</p><p>This approach is part of how we work at <a href="http://factors.design/">factors.design</a>, our design vertical, where we focus on building creative, human-centered solutions that address real-world problems. In the MedTech space, this means listening closely to practitioners, understanding the nuances of healthcare systems, and designing solutions that help bridge the gap between innovation and patient care.</p><p>MedTech is one of those rare spaces where design can be life-changing, when done right.</p><h3>The Role of AI and Real-Time Tech in Medicine</h3><p>Take something as niche and critical as fistula surgery. Dr. Chandan walked us through how understanding the exact layout of muscle and tract structures is crucial — because a single wrong cut can drastically impact a patient’s recovery, comfort, or even function. That’s where AI, combined with MRI imaging, has started playing a role in visualising 3D reconstructions before surgery.</p><p>It’s a powerful use of tech — not to replace the surgeon, but to assist them. As Dr. Chandan put it, AI isn’t here to take away jobs. It’s here to amplify good judgment.</p><p>With this ever-evolving tech, medical students and even experienced doctors need to keep themselves updated and afloat of the new up-comings. And it goes without saying, a lot of this learning happens through experience coupled with regular training sessions, seminars, webinars, and yes, YouTube. Now combine this with real-time 3D reconstructions? You unlock better decision-making, safer outcomes, and even new possibilities in medical training.</p><p>And it’s not just in the operating room (OR) where better design and technology can make a difference.</p><p>Our conversation naturally expanded beyond the OR. We discussed digital record keeping, the varying tech stacks in hospitals, and where systems start to break down. One pain point stood out sharply: the discharge process. A patient can be cleared by the doctor at 9 AM, but due to insurance-related paperwork and system lag, they may not leave the hospital till 6 PM.</p><p>That’s not just inconvenient — it clogs beds, delays incoming patients, and burdens families. These are the invisible cracks in the system that design has the potential to rethink.</p><p>And this is just scratching the surface. From AI to stem cells, 3D printing to surgical workflow optimisation, it’s clear the MedTech space isn’t short of innovation. What it often lacks is design that connects the dots between tech, people, and systems.</p><h3>Hunting for Problem Statements</h3><p>This is just the first of many conversations we’re having to understand the nuances of MedTech. We’re not here to reinvent the system, just to listen better, ask smarter questions, and design in ways that support the people who keep it running.</p><p>We’re actively seeking new problem statements to tackle. If you’re in the MedTech space or know someone who is, whether a practitioner, innovator, or product owner we’d love to hear from you and explore how we can contribute.</p><p>Let’s collaborate to build solutions that are creative, human-centered, and above all, real.</p><p><strong>Reach out to us on </strong><a href="https://www.linkedin.com/in/sk-sanjanakalra/"><strong>LinkedIn</strong></a><strong> or Check out some of our work &amp; case studies on </strong><a href="https://www.factors.design/"><strong>Factors.Design</strong></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9c57758b5258" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/designing-for-impact-in-medtech-lessons-from-the-or-and-beyond-9c57758b5258">Designing for Impact in MedTech: Lessons from the OR and Beyond</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Indian Fintech Landscape]]></title>
            <link>https://medium.com/non-zero-design/the-indian-fintech-landscape-1569eb679be7?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/1569eb679be7</guid>
            <category><![CDATA[finance]]></category>
            <category><![CDATA[indian-finance]]></category>
            <category><![CDATA[fintech-landscape]]></category>
            <category><![CDATA[fintech]]></category>
            <category><![CDATA[indian-fintech]]></category>
            <dc:creator><![CDATA[Soniya]]></dc:creator>
            <pubDate>Fri, 20 Jun 2025 07:30:27 GMT</pubDate>
            <atom:updated>2025-06-20T07:30:27.400Z</atom:updated>
            <content:encoded><![CDATA[<p>The Indian fintech ecosystem is a rapidly evolving domain, driven by widespread digital adoption, pivotal infrastructure like the Unified Payments Interface(UPI) and aggressive innovation.</p><p>This article is an attempt to map this ever-expanding landscape, explore key segments and the innovations that are reshaping financial services.</p><h4><strong><em>An Overview</em></strong></h4><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/f646a8b7b585ea2a128fdb45ef0bc38d/href">https://medium.com/media/f646a8b7b585ea2a128fdb45ef0bc38d/href</a></iframe><p>Let’s explore each one in detail.</p><h3><em>B2C (Business-to-Consumer)</em></h3><p>This segment focuses on financial products and services offered directly to individual consumers, leveraging digital channels for accessibility and convenience.</p><h4><em>Digital Payments &amp; Wallets</em></h4><p>Apps and services that facilitate quick money movement, both online and offline — from UPI to mobile wallets and POS transactions.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/17e45c5e4509b8093fa0129c6b9db4c1/href">https://medium.com/media/17e45c5e4509b8093fa0129c6b9db4c1/href</a></iframe><h4><em>Neobanking &amp; Mobile Banking</em></h4><p>Fully digital banking experiences built either on top of existing banks (Neobanks) or run by traditional players with modern UX (Mobile Banking).</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/f85330b60a57caf92084ae07ae7f8088/href">https://medium.com/media/f85330b60a57caf92084ae07ae7f8088/href</a></iframe><p><em>Neobanks in India can’t operate solo due to the Banking Regulation Act (1949), requiring them to team up with traditional banks.S</em></p><h4><em>Lending &amp; Credit</em></h4><p>Instant personal loans, Buy Now Pay Later, and peer-to-peer lending made possible via mobile, consent-driven access to bank data.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/5885516e60df0ddca30f503fb4317cc6/href">https://medium.com/media/5885516e60df0ddca30f503fb4317cc6/href</a></iframe><h4><em>Investments &amp; Wealth Management</em></h4><p>Platforms enabling retail users to invest in stocks, MFs, gold, and even real estate — all with better transparency and lower fees.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/47bfc213a1ba989e6cdcb10e281aaa37/href">https://medium.com/media/47bfc213a1ba989e6cdcb10e281aaa37/href</a></iframe><p><em>Jar’s daily gold savings model mimics the behavioral success of “Round-Up &amp; Save” in US apps.</em></p><h4><strong><em>Insurtech</em></strong></h4><p>Insurtech refers to apps and platforms that make it easier for users to buy, compare, and manage insurance online — often removing the paperwork, jargon, and sales-heavy middlemen that dominate traditional insurance.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/ddd7fe03f78864243f4a2bf42f8b744c/href">https://medium.com/media/ddd7fe03f78864243f4a2bf42f8b744c/href</a></iframe><p><em>In 2023, Acko became the first Indian digital insurer to cross 1 crore policies issued digitally, without agents.</em></p><h3>B2B (Business-to-Business)</h3><p>This segment provides financial services and tools tailored for businesses, from SMEs to large enterprises, enhancing their operational efficiency and financial management.</p><h4>SME Lending &amp; Financing</h4><p>SME lending fintechs help small businesses access <strong>working capital, invoice financing, equipment loans, and credit lines</strong> — often without collateral and entirely through digital journeys.<br>India has over <strong>6.3 crore MSMEs</strong>, many of whom are <strong>credit-starved</strong> due to rigid documentation needs, lack of formal credit history, and lengthy bank processes. (<a href="https://www.notion.so/Draft-01-1ffc41e1a15080d2b52ef535ec8a81f8?pvs=21">Source</a>)</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/ed49bd6fda064aacc183e656db8f32b6/href">https://medium.com/media/ed49bd6fda064aacc183e656db8f32b6/href</a></iframe><h4>Business Finance Management</h4><p><em>Helping businesses stay lean, compliant, and in control of their money.</em></p><p>As Indian businesses grow digitally, so does the need for smart tools to manage expenses, pay employees, automate tax filings, and stay compliant. What was once done on Excel and Tally is now being reimagined as intuitive platforms.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/74fad0f5eb6329349d8ab0cb32e44a87/href">https://medium.com/media/74fad0f5eb6329349d8ab0cb32e44a87/href</a></iframe><h4>Merchant Payments &amp; POS Solutions</h4><p>The hardware, software, and digital interfaces that help India’s businesses accept payments — fast, easy, and cashless.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*REF9c88vHQS_xY9fHns2wg.jpeg" /></figure><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/3ea7e602eaec3d55d35e0b16816ad18f/href">https://medium.com/media/3ea7e602eaec3d55d35e0b16816ad18f/href</a></iframe><h3>B2B2C (Enabling Others to Serve Consumers)</h3><p>While B2C apps get the headlines, many of them are built on top of <strong>invisible infrastructure players</strong>. These B2B2C fintechs offer tools, APIs, and white-labeled services that <strong>enable e-commerce sites, NBFCs, SaaS tools, or startups to offer financial products without building from scratch</strong>.</p><p>This layer is like the “AWS of fintech” — abstracting the banking complexity so others can innovate fast.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/998f7c0ce3b0fda9839b496218e5f9a6/href">https://medium.com/media/998f7c0ce3b0fda9839b496218e5f9a6/href</a></iframe><p>Difference between the layers</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/f9f6bfa3175847f0f3f2746030cc95b1/href">https://medium.com/media/f9f6bfa3175847f0f3f2746030cc95b1/href</a></iframe><p><em>M2P claims over 600 fintechs in India are built on their infra stack. (</em><a href="https://m2pfintech.com/pressrelease/M2P-Fintech-launches-a-first-of-its-kind-Core-Lending-Suite/"><em>Source</em></a><em>)</em></p><p><strong>Fintech infra is no longer optional — it’s modular.<br></strong>Companies can now pick what they need: just UPI, or full-stack banking, or lending. This “fintech Lego” is what powers the next 100 apps.<br><em>Many brands like Ola, Flipkart, MakeMyTrip offer insurance, credit, or wallet services — powered entirely by these infrastructure players.</em></p><h3>Infrastructure &amp; Platforms (IaaS / Fintech Infra)</h3><p><em>The invisible rails that power everything from payments to credit scoring.</em></p><p>These players aren’t always consumer-facing, but every UPI transaction, account verification, or instant loan <em>depends</em> on them.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/1b2f07bef3d5ed23be0c8eac282e2dae/href">https://medium.com/media/1b2f07bef3d5ed23be0c8eac282e2dae/href</a></iframe><h3>Crypto &amp; Blockchain</h3><p>This segment includes <strong>innovations that may not yet be fully integrated into India’s regulatory or financial systems</strong>, but are shaping the future of fintech globally and domestically.</p><p>It’s important to <strong>treat this as adjacent, not core infra</strong>, since much of it operates <strong>outside traditional compliance boundaries</strong> or is still in experimental phases.</p><iframe src="" width="0" height="0" frameborder="0" scrolling="no"><a href="https://medium.com/media/3149a87ddb09193520a2302fbec59430/href">https://medium.com/media/3149a87ddb09193520a2302fbec59430/href</a></iframe><p>While this is by no means an exhaustive overview. This is our attempt to understand, organize, and communicate this complex yet exciting ecosystem. It’s a starting point in our curiosity-driven exploration, which we’ll continue to refine and enhance through further research and insights.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1569eb679be7" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/the-indian-fintech-landscape-1569eb679be7">The Indian Fintech Landscape</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Selfridges Call That Changed Everything: MAGIC AI’s Bold MVP Play]]></title>
            <link>https://medium.com/non-zero-design/the-selfridges-call-that-changed-everything-magic-ais-bold-mvp-play-2024a3ef3bd5?source=rss----16b2d3138c21---4</link>
            <guid isPermaLink="false">https://medium.com/p/2024a3ef3bd5</guid>
            <category><![CDATA[ui]]></category>
            <category><![CDATA[ux]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[mvp]]></category>
            <category><![CDATA[product-design]]></category>
            <dc:creator><![CDATA[Cyrus Britto]]></dc:creator>
            <pubDate>Mon, 02 Jun 2025 06:43:09 GMT</pubDate>
            <atom:updated>2025-06-02T07:02:49.673Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/963/1*5tuGS1YjauqQbbdzmXZxvw.jpeg" /></figure><p>Every founder dreads that moment: your product isn’t quite ready, but a huge opportunity knocks. Do you take the leap or play it safe?</p><p>MAGIC AI, faced this dilemma when luxury retailer Selfridges wanted to showcase their AI fitness mirror. The catch? MAGIC AI barely had a working prototype.</p><p>This question came up again when I was chatting with Sunil Jindal, co-founder of <a href="https://magic.fit/">MAGIC AI</a> (the company behind that cool AI-powered fitness mirror).</p><blockquote>“Selfridges basically reached out to us and said, okay, can you sell this in our store? At the time, there was really no product,” Sunil told me.</blockquote><p>Talk about pressure!</p><h3>What’s Actually “Minimum” in an MVP?</h3><p>The whole point of an MVP is to test your core value proposition without burning months on features that might get tossed anyway. But here’s what they don’t tell you in startup school: the “minimum” varies wildly depending on who you’re selling to and what you’re charging.</p><p>When Magic AI faced their Selfridges opportunity, they took a pragmatic approach:</p><blockquote>“We dumbed it down and said, okay, we need like an even simpler version that we can use for demoing in the store,” Sunil explained.</blockquote><p>Their first version had just six exercises to demonstrate the tracking technology — nothing fancy, just enough to show what made their product special.</p><p>This approach isn’t unique to Magic. Often used examples are:</p><p>Airbnb, Dropbox, and Groupon all started with bare-bones MVPs that nailed the core offering.</p><figure><img alt="Captured this moment with Sunil at Selfridges back in September 2024, at the mirror installation in its current iteration." src="https://cdn-images-1.medium.com/max/1024/1*Y9_lPmRmjiW3l7ujjh2_7w.jpeg" /><figcaption>Captured this moment with Sunil at Selfridges back in September 2024, at the mirror installation in its current iteration.</figcaption></figure><h3>The Price-Polish Equation</h3><p>Here’s where context matters enormously. Magic AI wasn’t selling a $5 app — they were selling a premium fitness device that costs hundreds of pounds.</p><blockquote>“The fact that Magic is a premium product, people are paying a lot of money for, the expectation is higher,”</blockquote><p>This is what I call the Price-Polish Equation: as your price point increases, so does the minimum acceptable level of polish.</p><p>But even with premium products, you still need to prioritize. As Sunil put it: “We’ve got to balance it out with not spending time on something that’s not high priority in terms of design, like 80,20-ing it basically.”</p><p>The first version wasn’t perfect, and Sunil was refreshingly honest about it: “There were quite a few negative comments back then, and they were very understandable… the product wasn’t in an amazing place when we first started, which is very common.” What mattered most was what came next: “What was key for us is quickly improve things and we did do that.”</p><h3>The Founder’s MVP Checklist</h3><p>So where does this leave you? Instead of obsessing over “how polished,” consider “polished in which ways?” Here’s my quick checklist:</p><ol><li><strong>Does it demonstrate your core value?</strong> Magic focused on showing their tracking technology worked, even with a bare-bones UI. Research shows users forgive rough edges if the core value is clear.</li><li><strong>Does it meet expectations for its price point?</strong> A $10,000 product can’t look like it was built in a weekend. Consider the context of your offering.</li><li><strong>Have you avoided the feature creep trap?</strong> According to research, the #1 MVP mistake is including too many features. Focus ruthlessly on what matters.</li><li><strong>Can you rapidly improve it?</strong> The most successful MVPs aren’t static — they evolve quickly based on user feedback.</li></ol><p>The biggest lesson from MAGIC AI’s story? Sometimes, getting to a phenomenal product means starting with something that’s not.</p><p>So what’s your MVP’s core value, and what parts could you launch without? That’s the question worth obsessing over.</p><p>If you’re wrestling with your own MVP decisions or want to chat about product strategy, drop by at <a href="http://notforthefaint.space/">notforthefaint.space</a> — it’s where we help founders navigate these exact dilemmas through our startup wing at Non Zero Design.</p><p>Cheers!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=2024a3ef3bd5" width="1" height="1" alt=""><hr><p><a href="https://medium.com/non-zero-design/the-selfridges-call-that-changed-everything-magic-ais-bold-mvp-play-2024a3ef3bd5">The Selfridges Call That Changed Everything: MAGIC AI’s Bold MVP Play</a> was originally published in <a href="https://medium.com/non-zero-design">Non Zero Design</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>